Endocrine Society Advocacy Win: Congress Increases FY 2026 NIH Funding Last month, Congress finally passed a funding bill for the Department of Health & Human Services for fiscal year (FY) 2026. The bill includes an increase of about $415 million for the National Institutes of Health (NIH), including a $10 million increase for diabetes research, and language the Endocrine Society had advocated for to protect the NIH by limiting a budget maneuver called multi-year funding, prohibiting arbitrary caps to indirect cost rates, requiring grants be paid within five business days, and reclaiming congressional authority over spending.
This was a major victory considering that originally the administration proposed a 40% cut to NIH research, cancelled thousands of grants, and proposed restructuring the NIH in ways that would disrupt endocrine research. While the Endocrine Society was not the only group advocating for funding for the NIH, we were one of the most vocal.
We worked for a year to achieve our goals and successfully used online advocacy campaigns, Hill Days, visits to congressional offices, and briefings to influence.
Endocrine News published a clinical update in Research Highlights on 02 Mar 2026.
The item focuses on Endocrine Society Advocacy In Action – March 2026.
Review the original article for the full source wording and details.